Clinical Trial Results

Showing: All studies [change]
Condition: Kidney Disease Location: Portland, Oregon 7 trials found
New Search
Filter
Trial Phase
What's the difference?
Study Type
What's the difference?
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
The Use of Risk Prediction to Identify Patients at Risk for Chronic Kidney Disease: Patient and Provider Interventions for Patients at High Risk for Chronic Kidney Disease
NAINTERVENTIONAL Portland, Oregon
RECRUITING
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
PHASE4INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Ferric Citrate and Chronic Kidney Disease in Children
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
PHASE3INTERVENTIONAL Stanford, California +4 more
RECRUITING
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
PHASE3INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Persona Revision Knee System Outcomes
N/AOBSERVATIONAL Fayetteville, Arkansas +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type